Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 40,497 | 36,855 | 26,581 | 43 | 828 |
| Gross Profit | 40,497 | 36,855 | 26,581 | 43 | 828 |
| Operating Expenses | 113,833 | 216,525 | 230,348 | 168,901 | 88,938 |
| Operating Income | -73,336 | -179,670 | -203,767 | -168,858 | -88,110 |
| Interest Expense | 3,874 | 4,073 | 3,328 | 1,267 | 359 |
| Other Income | 8,436 | 12,073 | 2,883 | 65 | 424 |
| Pre-tax Income | -68,774 | -171,670 | -204,212 | -170,060 | -88,045 |
| Income Tax | 418 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -69,192 | -171,670 | -204,212 | -170,060 | -88,045 |
| Net Income | $-69,192 | $-171,670 | $-204,212 | $-170,060 | $-88,045 |
| EPS Basic Total Ops | -14.00 | -37.00 | -54.50 | -60.25 | -35.75 |
| EPS Basic Continuous Ops | -14.12 | -36.96 | -54.51 | -60.24 | -35.80 |
| EPS Diluted Total Ops | -14.00 | -37.00 | -54.50 | -60.25 | -35.75 |
| EPS Diluted Continuous Ops | -14.12 | -36.96 | -54.51 | -60.24 | -35.80 |
| EPS Diluted Before Non-Recurring Items | -14.00 | -37.00 | -54.50 | -60.25 | -35.75 |
| EBITDA(a) | $-75,625 | $-182,722 | $-204,302 | $-168,003 | $-87,186 |